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DOI 10.1186/s13063-015-0628-yRESEARCH Open AccessMixed methods feasibility study for a trial of
blood pressure telemonitoring for people who
have had stroke/transient ischaemic attack (TIA)
Janet Hanley1,2*, Peter Fairbrother4, Ashma Krishan2, Lucy McCloughan3, Paul Padfield3, Mary Paterson3,
Hilary Pinnock3, Aziz Sheikh3, Cathie Sudlow3, Allison Todd4 and Brian McKinstry2,3Abstract
Background: Good blood pressure (BP) control reduces the risk of recurrence of stroke/transient ischaemic attack
(TIA). Although there is strong evidence that BP telemonitoring helps achieve good control, none of the major trials
have considered the effectiveness in stroke/TIA survivors. We therefore conducted a feasibility study for a trial of BP
telemonitoring for stroke/TIA survivors with uncontrolled BP in primary care.
Method: Phase 1 was a pilot trial involving 55 patients stratified by stroke/TIA randomised 3:1 to BP telemonitoring
for 6 months or usual care. Phase 2 was a qualitative evaluation and comprised semi-structured interviews with 16
trial participants who received telemonitoring and 3 focus groups with 23 members of stroke support groups and
7 carers.
Results: Overall, 125 patients (60 stroke patients, 65 TIA patients) were approached and 55 (44%) patients were
randomised including 27 stroke patients and 28 TIA patients. Fifty-two participants (95%) attended the 6-month
follow-up appointment, but one declined the second daytime ambulatory blood pressure monitoring (ABPM)
measurement resulting in a 93% completion rate for ABPM − the proposed primary outcome measure for a full trial.
Adherence to telemonitoring was good; of the 40 participants who were telemonitoring, 38 continued to provide
readings throughout the 6 months. There was a mean reduction of 10.1 mmHg in systolic ABPM in the telemonitoring
group compared with 3.8 mmHg in the control group, which suggested the potential for a substantial effect from
telemonitoring. Our qualitative analysis found that many stroke patients were concerned about their BP and
telemonitoring increased their engagement, was easy, convenient and reassuring.
Conclusions: A full-scale trial is feasible, likely to recruit well and have good rates of compliance and follow-up.
Trial Registration: ISRCTN61528726 15/12/2011.
Keywords: Hypertension, Stroke, Transient Ischaemic Attack, General Practice, Home monitoring, Telemonitoring, Pilot
Randomised Controlled Trial, Qualitative ResearchBackground
Ageing populations present a major challenge for health
service planners worldwide. Policymakers in many coun-
tries see telehealth as a core component of plans to re-
organise the management of long-term conditions [1,2],
but it is not clear for which types of condition or for* Correspondence: j.hanley@napier.ac.uk
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unless otherwise stated.which patients this approach is likely to be most benefi-
cial. In areas such as heart failure and chronic obstruct-
ive pulmonary disease, initial optimism surrounding
telemonitoring – an application of telehealth where pa-
tients take measurements at home with a telemetry link
to a healthcare provider – has been tempered by the
more circumspect results from high-quality randomised
controlled trials [3,4] and by the challenges of moving
these interventions on from small demonstrator projects
to normalise them into routine care at scale [5,6].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the world after ischaemic heart disease, causing around
9% of all deaths; it is also the commonest cause of adult
disability in developed countries [7,8]. Raised blood
pressure (BP) is the most important reversible risk factor
for first or recurrent stroke, with risk increasing by
about one-third for every 10 mmHg increase in systolic
BP [9]. Patients with a previous stroke or transient ischae-
mic attack (TIA) have a particularly high risk of subse-
quent stroke, which is mitigated by long-term reduction
in BP [10,11]. The greater the reduction in BP is, the
greater the benefit, at least down to about 130/70 mmHg;
few however achieve this challenging target [12,13].
There is strong evidence from systematic reviews
[14,15] and recent randomised controlled trials [16,17]
that telemonitoring is an effective way to achieve BP
reduction in a general hypertensive population. However,
telemonitoring is a complex intervention, sensitive to
the context in which it is applied [18]. It cannot be as-
sumed that the benefits seen in the general hypertensive
population will necessarily apply in people with stroke
or TIA (even though they have more to gain from good
BP control), as they may be more debilitated [19,20] with
more complex polypharmacy than the populations previ-
ously studied. Furthermore, clinicians may be cautious
about lowering BP in these often elderly patients and,
while only a minority of stroke and TIA survivors have
severe residual disability [19], minor physical or cogni-
tive disability may reduce the ability to use a BP moni-
toring system. Although there is evidence that some
stroke and TIA survivors are willing and able to self-
monitor their BP without telemonitoring [21,22], it did
not improve BP control compared to a control group, in
concordance with the limited impact of unsupported
home BP monitoring found in trials in the general popu-
lation [23,24]. Stroke/TIA survivors have not been stud-
ied as an a priori sub-group in previous telemonitoring
trials [14-17], and poorer (or better) outcomes in stroke
survivors may therefore have been masked. We aimed to
test the feasibility of mounting a pragmatic randomised
controlled trial of BP telemonitoring in patients who had
a previous stroke/TIA in a UK primary care setting,
using a protocol that had been effective in our previous
trial [17] but that excluded this patient group. Our feasi-
bility study aimed to investigate the likely recruitment
rate to a trial, feasibility of using the telemonitoring
service and the experiences and perspectives of those
using the telemonitoring service and those who may not
choose to do so.
Methods
There were two major components to our mixed-
methods evaluation. Phase 1 was a pilot trial involving
stroke/TIA patients randomised in a ratio of 3:1 totelemonitoring or usual care. Phase 2 comprised inter-
views with pilot trial patients and nurses as well as focus
groups with patients and carers attending stroke support
groups. The study was approved by the South East
Scotland Research Ethics Service (reference 11/SS/0023).
Phase 1: Pilot trial
We undertook a pilot researcher-blinded randomised
controlled trial in six socio-economically diverse general
practices in Lothian, South East Scotland, to test the
feasibility of the trial processes and measures. We in-
cluded patients over 18 years of age with a history of
stroke or TIA, whose most recent office-based BP meas-
urement and subsequent daytime average ambulatory
systolic BPs both exceeded 130 mmHg. Patients were ex-
cluded if they had: secondary hypertension; hypertension
being managed in secondary care; a surgery measured
BP of ≤120/60 mmHg or ≥220 mmHg systolic at the
baseline research visit; terminal illness or major concur-
rent illness where treatment was likely to affect the
ability to self-monitor; stroke within the last 3 months;
major surgery within the last 3 months; atrial fibrillation
(which would cause error messages from the automatic
oscillometric monitors used); or inability to consent or
use self-monitoring equipment alone and with no easy
access to help. Details of the telemonitoring service are
shown in Figure 1.
GPs from participating practices identified potentially
eligible patients from practice computer records with
the assistance of the Scottish Primary Care Research
Network and outlined the study in a letter inviting them
to express an interest via a reply slip. For stroke patients
this correspondence included the patient information
letter in regular format and stroke-accessible format.
Stroke patients known to have disabilities that limited
their ability to cope with written information were also
telephoned by a member of the practice staff if necessary
to ensure that they had received the information in an
accessible format and that they were able to respond
and return the reply slip if interested. Patients expressing
an interest were contacted by the research nurse who
arranged an appointment to see them at the practice
(or at home if necessary).
The research nurse explained the intervention, dem-
onstrated the equipment and gave the patient the oppor-
tunity to consider whether they would be able to use the
equipment (either alone or with help) or not. The re-
search nurse obtained informed consent from people
who were willing and able to participate in the trial.
Consenting patients had BP measured electronically
three times (a mean of the second and third were calcu-
lated) using the IEM stabilograph also used for home
monitoring, and daytime ambulatory monitoring using a
Spacelabs 902 monitor was initiated unless surgery
Figure 1 The intervention.
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systolic. In these instances the patient would either be
advised that they were unlikely to require further treat-
ment to optimise their BP or that their BP was very high,
with onward referral to their GP. On return of the am-
bulatory monitoring equipment, patients whose average
daytime ambulatory systolic BP exceeded 130 mmHg
were asked to complete a number of questionnaires as
baseline measurements including the Hospital Anxiety
and Depression Score (HADS) [25], the EQ 5D quality
of life measure [26] and the Stroke Impact Scale [27].
Patients’ disability was assessed using the Modified
Rankin Scale [28] and with regard to the level of help
that may be required from a carer in the use of the
equipment. They were randomised after baseline data col-
lection using a remote Internet-based system provided by
the Edinburgh Clinical Trials Unit (accessible by tele-
phone if necessary) to telemonitoring or usual care.
All patients were provided with an information pack
on lifestyle measures to reduce BP. Intervention patients
were taught how to use the equipment. Both the office
and daytime ambulatory measurements were reported to
the patients’ GP practice. Throughout the trial, patients
were reviewed according to clinical need by their usual
clinical advisors. Patients were encouraged to contact
their doctor in the usual way in emergencies or if con-
cerned. Therapeutic algorithms for both intervention
and control groups were provided to practices. These
followed existing local guidelines, based on National
Institute for Health and Clinical Excellence (NICE)/
British Hypertension Society (BHS) guidelines [29,30]
(see Additional file 1), but included minimum timelines
for escalation of therapy (which had not been needed
prior to the introduction of telemonitoring and instantavailability of home monitored BP). As with all Lothian
guidelines, their use was discretionary.
Patients remained in the trial for 6 months after which
the baseline measures were repeated. It was not possible
to blind the patients or clinicians to the allocation,
potentially introducing bias. However, all trial outcome
data collection was undertaken by a second research
nurse, blinded to allocation, and patients were requested
not to reveal allocation. Patients in the intervention arm
were asked to return the telemonitoring equipment to
surgery staff when they returned the ambulatory moni-
tor so as not to unblind the research nurse. Use of
healthcare resources (number and duration of hospital
admissions), practice and out-of-hours consultations,
routine reviews for BP, prescriptions for anti-hypertensive
drugs and adverse events were extracted from the patients’
primary care record by the research nurse. All adverse
events were recorded, specifically noting falls, dizzy spells
and postural hypotension. Adverse events were assessed
for seriousness by BM, a GP who was blinded to alloca-
tion. After the initial data analysis, telemonitoring re-
cords were retrieved and analysed for compliance with
monitoring.
The sample size was limited to around 50 by the avail-
ability of equipment and a target sample size of 56 par-
ticipants was set, to be randomised in a 3:1 ratio with 42
in the active treatment arm and 14 in the control arm.
This ratio was chosen to maximise the number of pa-
tients trying telemonitoring whilst still piloting full trial
procedures. We were particularly interested in being
able to estimate the likely proportion of patients discon-
tinuing telemonitoring. If 6/42 (14.3%) discontinued tel-
emonitoring, this would give a confidence interval (CI)
around the estimate of 6.7% to 27.8%. We considered
Hanley et al. Trials  (2015) 16:117 Page 4 of 10this would provide adequate information to inform the
design of the large-scale trial. We also anticipated that
stroke patients may be more difficult to recruit than TIA
patients. To ensure adequate inclusion of the potentially
more disabled stroke patient group, we purposely in-
cluded 50% stroke patients and 50% TIA patients, strati-
fying randomisation by stroke/TIA status. Data were
analysed using descriptive statistics. Since this pilot was
not conducted or powered to detect effects on BP, we
did not carry out formal tests of statistical significance.
Phase 2: Qualitative research
The qualitative part of this mixed methods evaluation
had two components because we wanted to explore the
experience of those taking part in the pilot trial and the
views of a wider group of stroke survivors who may
not have expressed interest in the trial because they
either could not, or did not want to, monitor their own
BP. For the latter, a number of focus groups were re-
cruited from stroke survivors and their carers who were
attending Chest Heart and Stroke Scotland (a national
charity) stroke support groups. In the focus groups, the
equipment was demonstrated and participants were
given the opportunity to try fitting the cuff and then
asked to discuss whether, if their practice offered it, they
would wish to use the home monitoring service. In
addition, a purposive sub-sample of patients recruited to
the pilot trial were interviewed about their experiences
of using the equipment and participating in the trial. The
interviews were semi-structured and were undertaken with
the help of an interview guide (Additional file 2). Carers
were also invited to take part in interviews, if appropriate.
A maximum variation sample in relation to patient age,
social class, disability and BP control at recruitment was
sought for the interviews to elicit the widest range of
experience possible. Interviews and focus groups were
carried out by PF, a male social scientist, and additional
written, informed consent was obtained from all partici-
pants. Interviews and focus groups were digitally audio re-
corded and transcribed in full. Given the communication
issues that can follow stroke [31,32], pictorial communica-
tion aids (‘talking mats’ [33]) were used to assist expression
and comprehension in the focus groups. This approach is
described in more detail elsewhere [34]. In order to gain
comparative insights, three practice nurses providing the
telemonitoring service in this study who had also been in-
volved in our previous BP telemonitoring trial in patients
who had not had a stroke or TIA [32] were also inter-
viewed. Interviewing continued until the researcher, in
discussion with the wider research team, considered that
data saturation was achieved, which, in the context of this
study, was considered to have occurred when the re-
searcher was not identifying any new themes and thought
this would be unlikely in subsequent interviews.Data analysis of the interviews and focus groups was
thematic. As well as exploring the anticipated themes
arising from our previous BP telemonitoring study [35],
researchers also specifically searched for emergent, un-
anticipated themes. A range of strategies was employed
to ensure that the analysis was credible and trustworthy.
Constant comparison was used to ensure consistency in
coding and negative cases were sought for each coding
category. Initial coding was carried out by PF. Coding
was checked and iteratively refined using paired analysis
of transcripts by PF and another researcher. Researcher
reflexivity was supported by discussing emerging find-
ings with a wider research group where different expla-
nations were explored and the coding and thematic
analysis were reviewed and refined. Following this, the
thematic analysis was presented by JH to a discussion
group of nine patients, professionals and researchers
who had participated in the pilot trial. The presentation
introduced the themes and illustrative quotes and the
whole data set (all the text associated with each code)
was made available to the participants. This discussion,
which lasted for 90 min, was moderated by LM.
Results
Phase 1: Pilot trial
Six general practices participated in the pilot. The
subject flow through the pilot trial is shown in Figure 2.
Overall, 125 patients (60 stroke patients, 65 TIA pa-
tients) were approached and 55 (44%) including 27 (45%
of those approached) stroke patients and 28 (43%) TIA
patients were randomised. Recruitment stopped at 55
participants because engaging another practice to recruit
and manage one additional patient seemed unreason-
able. Overall 52 participants (95%) attended the 6-month
follow-up appointment but 1 declined the second ABPM
measurement resulting in a 93% completion rate for
ABPM—the proposed primary outcome measure for a
full trial. The participant characteristics are shown in
Table 1. Two participants needed help from a carer to
use the equipment and they were the same two with
moderate/severe disability on the modified Rankin scale.
The stroke impact scale (Table 2) confirmed that, as a
group, the stroke participants in the pilot trial were not
severely disabled. However, at baseline a high proportion
of participants [18 (67%) stroke and 22 (79%) TIA pa-
tients] had scores on the HADs anxiety subscale of >11,
likely to indicate clinically significant anxiety [36].
Compliance with telemonitoring was good. Of the 40
participants who were telemonitoring, 38 continued to
provide readings throughout the 6 months, although one
provided fewer than the minimum number of readings
requested, giving a rate of 97% full compliance. The out-
come measures are shown in Table 2. The mean reduc-
tion of 10.1 (SD 15.6) mmHg in systolic ABPM in the
Figure 2 Patient flow through the study.
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Table 1 Patient characteristics at baseline
Intervention N = 40 Control N = 15
Male/female (number) (Total group) 27/13 6/9
Stroke group 14/6 2/5
TIA group 13/7 4/4
Age – mean in years (SD) (Total group) 69.9 (12.6) 73.5 (11.7)
Stroke 67.8 (14.5) 69.1 (7.9)
TIA 72.0 (10.2) 77.3 (13.6)
Modified Rankin Scale (stroke patients only) - number
No symptoms 7 2
No significant disability 4 3
Slight disability 7 1
Moderate disability 1 1
Moderately severe disability 1
Stroke Impact Scale score (stroke patients only) – mean (SD)
0 = no recovery 100 = full recovery
Dimension
Physical 78.1 (25.4) 84.8 (19.4)
Memory 78.9 (23.2) 84.2 (23.7)
Emotional 78.9 (16.3) 81.0 (11.9)
Communication 86.3 (19.4) 90.8 (21.3)
Activities of daily living 82.3 (22.4) 92.9 (5.9)
Mobility 78.7 (22.0) 85.7 (11.4)
Hand function 72.5 (30.9) 85.0 (25.7)
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in the control group suggested the potential for a sub-
stantial effect from telemonitoring. Overall 15/36 (42%)
of the telemonitoring group compared with 2/15 (13%)
of the control group reached the target systolic ABPM
of < 130 mmHg at follow-up. Mean changes to anxiety
and depression scores in the intervention group were
minimal. The use of healthcare resources with a com-
parison to the previous 6 months is shown in Table 3
and changes to anti-hypertensive medication in Table 4.
These figures suggest that there was an increase in GP
contacts and medication changes in both the interven-
tion and control groups in response to the ABPM re-
sults, which were communicated to the practices, and to
telemonitoring. There were eight adverse events during
the trial period, only two, both non serious, of whichTable 2 Outcome measures
Baseline
Intervention N = 40 Contro
Daytime ABPM systolic mmHg (SD)
(proposed primary outcome)
144.1 (10.3) 143.6 (9
Daytime ABPM diastolic mmHg (SD) 79.2 (7.8) 77.7 (8.
Mean HADs Anxiety score (SD) 11.8 (2.7) 12.1(2.4
Mean HADs Depression score (SD) 8.9 (1.7) 9.0 (2.8may have been BP related, with one of these in each
group.
Phase 2: Qualitative research
Sixteen trial participants were interviewed (mean age
66 years, 8 stroke, 8 TIA, 12 male, 4 female) plus 23
patients (7 with their carer) in the three stroke support
focus groups (mean patient age 68 years, 11 female, 12
male). The coded data from the transcripts of these
interviews were grouped into sub-themes and further
grouped into three overarching themes (usual care; try-
ing the new technology; benefits and burdens of telemo-
nitoring) plus a fourth theme on the context of the
research study. The first three themes, with illustrative
quotes, are presented below. Four professionals were
interviewed (three nurses who had also participated in6 months
l N = 15 Intervention N = 37 (36 for ABPM) Control N = 15
.6) 133.9 (13.6) 139.8 (15.5)
1) 75.2 (7.4) 76.9 (9.6)
) 12.0 (3.0) 12.9 (1.8)
) 8.7 (1.4) 8.8 (2.1)
Table 3 Healthcare usage in the 6 months before and after baseline
Total healthcare contacts in 6 months prior to
baseline visit
Total healthcare contacts in 6 months after
baseline visit
Intervention group N = 37 Control group N = 15 Intervention group N = 37 Control group N = 15
GP visits/patient 36 33 95 57
Practice nurse visits/patient 64 24 68 36
Phone calls/patient 20 11 48 24
A&E attendances (total) 2 1 2 2
Out of hours (total) 1 1 2 2
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co-ordinator). The transcripts of interviews with the
nurses were read to identify any evidence that they per-
ceived any difference between supporting BP telemoni-
toring with stroke/TIA patients and other patients. No
such evidence was found and no new themes identified
compared to the findings of our previous study of BP
telemonitoring in non-stroke patients [32]. Therefore,
the analysis of the professional interviews is not pre-
sented here, but will be included in a wider analysis of
professional experience of telemonitoring BP to be pub-
lished elsewhere.
Usual care
The participants involved in both the pilot trial and the
focus groups were aware that elevated BP is a risk factor
for another stroke and were therefore very concerned
about it.
“You’re sent here and you cannae drive your car and
you’re just somebody who’s had a stroke and they’re
telling you you’re going to have another, and you’re just
sitting there wondering if it’s going happen again, hey?”
Female, 54, TIA
However, many were not engaged in their BP manage-
ment with about half commenting they were never told
what their BP reading was when it was checked in the
surgery. None of those participating said they owned a
BP monitor although two mentioned the possibility.
“I’ve never seen the results of my blood pressure at any
time. Because the nurse takes it, ‘how is it?’ ‘It’s fine’.”Table 4 Anti-hypertensive medication changes during the
study
Intervention
group N = 37
Control
group N = 15
Total number of new drugs prescribed 18 8
Total number of drugs discontinued 5 8
Total number of dosage changes 25 15Male, focus group (participants only identifiable by sex
in focus groups)
Making appointments and going to the surgery for BP
checks was inconvenient and time consuming, especially if
appointments were frequent. In addition, patients were
aware that surgery BP was not always an accurate indicator.
“…you have to walk and get an appointment or phone
for an appointment and wait 20 hours for it, go to one,
go to two, go to three [appointments]…”
Male, 62 years, stroke
“…where people have white coat syndrome, where as
soon as they go to the practice, their blood pressure
goes up, you know. And I've always been like that”
Male, 64 years, TIA
Trying the new technology
Generally, patients participating in the pilot trial found that
taking their BP readings and transmitting them was easy
and non-intrusive, although a small number felt that they
needed some reassurance that they were doing it correctly.
“I’m quite happy doing it at home, although I think in
the very near future I’ll make an appointment with
either my GP or the practice nurse, to take a reading
on site, just to make sure that it’s actually performing
accurately. I don’t believe, for one minute, it’s not, but
I think a double check would be in order, because it
has, broadly speaking, come down…you’re looking at
anything to 15 percent, overall”.
Male, 53 years, stroke
However, when members of the stroke support groups
were given the opportunity to try the system, most could
not fit the cuff and many said they would not have
access to help.
Most people found the system worked smoothly, and
any minor technical issues or queries were resolved by the
trial manager, who acted as the system manager during
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dialogue with the surgery regarding their measurements
should be initiated and, although there was automatic
feedback from the system, patients were not always sure
that their readings had been reviewed by the practitioners.
“So the system’s working okay; I don’t know whether
they’re reading it, … but the only concern I have now
is that the latest one [automatic feedback from system]
which I mentioned came in a couple of days ago
through the internet, an email expressing some
concern. Now, I haven’t had any word from the
surgery [name removed] to that effect either, but they
may be snowed under or whatever”.
Male, 84 years, stroke
Patients tended to be called in to the surgery if there
was concern about their BP and, on some occasions
where the nurses monitoring the system were not pre-
scribers, there appeared to be a lack of communication
within the healthcare team.
“Somebody phoned me to say, ‘We’re not happy with
your blood pressure reading, you’ve got to go and see
your doctor…make an appointment to see your
doctor…’ He just said, ‘Oh it’s fine…your blood pressure
is fine now’”.
Male, 66 years, stroke
Benefits and burdens of home telemonitoring
The key benefits reported were a credible estimate of BP,
even when it was higher than expected, convenience and
reassurance, with the use of the system being preferable
to usual care. Patients also thought that their measuring
their BP at home released time for the practice.
“Well, obviously I got a surprise because it's worse than
what I already had anticipated it was. It's obviously…I
think my BP had been sneaking up a wee bit”.
Male, 64 years, TIA
“It’s certainly, from my point of view, my selfish point of
view, it’s very convenient not to have to make a journey
to the doctor’s when it’s only to have BP checked”.
Female, 93 years, TIA
“…it doesn’t make sense wasting the doctor’s time,
wasting my time when I can do it sitting at the table”.
Male, 84 years, stroke“It, certainly, takes the worry away, you know, you’re not
sitting wondering, you know, I wonder what my BP is, if
you’re using that, I’ve never even thought about it”.
Male, 70 years, TIA
The telemonitoring data also supported self-management
by some and helped patients to be more engaged in the
medical management of their condition.
“…it went up to 160…And then I was thinking, on the
Sunday night I run out of decaffeinated coffee and I
started drinking ordinary coffee, and my BP for that
week was in the 150 s, right?…I got more decaff and
the BP…Aye, it was up here, so it went from 150 down
to 130, is it possible?”
Male, 80 years, stroke
The burdens reported by the patients were minimal,
the main burden being remembering to take the read-
ings. One person said that abnormal readings could
make them anxious.
“there was a date when I gave some very low readings.
That actually worried me more!”
Male, 53 years, stroke
Discussion
This mixed-methods feasibility study showed that a trial
of telemetry supported home BP monitoring for patients
who have had stroke/TIA is both feasible and, based on
the response rate and qualitative data, would be wel-
comed by this patient group. Rates of recruitment and
retention in the pilot trial were high. The data also sug-
gest that it should be possible to improve BP control in
this group. Only a small proportion of those in the pilot
trial had significant residual disability, which is consist-
ent with published data on stroke survivors [18], and
those who did had assistance to use the equipment.
However, the work with the stroke support groups iden-
tified some people who would be unable to use the
equipment and may not have access to assistance.
The participants in the pilot trial were, on average,
older (mean age 71 years) than participants in previous
reported trials of BP telemonitoring [13-16]. They also
reported more symptoms of anxiety and depression than
participants in other trials [16], although there was little
change in these measurements associated with the inter-
vention, providing some reassurance that the interven-
tion does not have an adverse effect on mental health.
The qualitative data showed that participants were aware
of the risk of high BP and further stroke and concerned
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ously been routinely told their BP measurement when it
was checked in the practice. It is therefore unsurprising
that many welcomed the opportunity to become more
engaged in their BP management and some found home
BP monitoring reassuring, as well as being convenient.
This study has demonstrated that improvement in BP
control in stroke/TIA survivors is feasible. Based on the
results of this pilot, a trial would require 111 subjects per
group, assuming a mean systolic ABPM of 134 mmHg
(SD 15) with the power to detect a difference of 4 mmHg
between groups (based on the outcome of our previous
trial [17]) set at 0.9 and α = 0.05. A trial would also be re-
quired to estimate the likely impact of BP telemonitoring
for this group on health services. As seen previously [17],
the introduction of telemonitoring appeared to be associ-
ated with an increase in healthcare usage, especially phone
calls and medication changes. However, in this feasibility
study healthcare usage also increased in the control group
where there were, pro rata, more medication changes than
in the intervention group. This may have been as a result
of the decision to disclose the result of the baseline ABPM
for all patients (this was not done in our previous BP tele-
monitoring trial [17] but was done in this pilot as in the
intervening period the NICE guideline 127 [27] had been
issued recommending ABPM for diagnosis of hyperten-
sion). Alternatively it may have been a chance finding with
high consultation rates being a characteristic of this small
control group that also had high levels of healthcare
consultation prior to the study starting.
Conclusions
The findings from this study suggest that a full-scale
trial is feasible, likely to recruit well and have good rates
of compliance and follow-up, and would be required
before a definitive statement on the effectiveness of
telemonitoring for this group can be made.
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